Qiu-Hua Zhong

8PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingCancer cell biologyCondensed matter characterisation technique developmentCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 11, 2024
Mitogen-Activated Protein Kinase 15 Is a New Predictive Biomarker and Potential Therapeutic Target for Ovarian Cancer.

Qiu-Hua Zhong, Andy T Y Lau, Yan-Ming Xu

|Mar 11, 2023
The Atypical MAP Kinase MAPK15 Is Required for Lung Adenocarcinoma Metastasis via Its Interaction with NF-κB p50 Subunit and Transcriptional Regulation of Prostaglandin E2 Receptor EP3 Subtype.

Fei-Yuan Yu, Qian Xu, Xiao-Yun Zhao

|Jan 08, 2023
Effects of CYP3A43 Expression on Cell Proliferation and Migration of Lung Adenocarcinoma and Its Clinical Significance.

Qi-Yao Wei, Andy T Y Lau, Hai-Ying Mo

|Jul 27, 2022
Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling Pathway.

Hai-Ying Mo, Qi-Yao Wei, Qiu-Hua Zhong

|Jun 13, 2022
Recent knowledge of NFATc4 in oncogenesis and cancer prognosis.

Qiu-Hua Zhong, Si-Wei Zha, Andy T Y Lau

|Jan 23, 2022
ACC2 is under-expressed in lung adenocarcinoma and predicts poor clinical outcomes.

Fei-Yuan Yu, Qian Xu, Qi-Yao Wei

Pageof 2

Frequent Collaborators

8 joint publications

Andy T Y Lau

8 joint publications

Yan-Ming Xu

5 joint publications

Xiao-Yun Zhao

4 joint publications

Hai-Ying Mo